Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro
Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infections as they are inherently refractory to many types of antibiotics. Treating biofilms with phage h...
Gespeichert in:
Veröffentlicht in: | PloS one 2019-01, Vol.14 (1), p.e0209390-e0209390 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0209390 |
---|---|
container_issue | 1 |
container_start_page | e0209390 |
container_title | PloS one |
container_volume | 14 |
creator | Dickey, James Perrot, Véronique |
description | Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infections as they are inherently refractory to many types of antibiotics. Treating biofilms with phage has shown promise in a handful of experimental and case studies. However, quantification of the effect of phage combined with antibiotics is needed to pave the way for larger clinical trials. Here we explore the effect of using phage in combination with a total of nine antibiotics, applied simultaneously or as a pretreatment before antibiotics are applied to in vitro biofilms of Staphylococcus aureus. Most antibiotics alone were ineffective at low concentration (2×MIC), but the addition of phage to treatment regimens led to substantial improvements in efficacy. At high concentration (10×MIC), antibiotics alone were effective, and in most cases the addition of phage to treatment regimens did not improve efficacy. Using phage with rifampin was also very effective at reducing the outgrowth of resistant strains during the course of treatment. |
doi_str_mv | 10.1371/journal.pone.0209390 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2167787078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A569840693</galeid><doaj_id>oai_doaj_org_article_60194332455e471dbdcbd1c33de4c54a</doaj_id><sourcerecordid>A569840693</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-f2404006212473ecd79a15d783819bd7d296227fe0137905e0f40b6ebceb5efb3</originalsourceid><addsrcrecordid>eNqNk1-L1DAUxYso7jr6DUQDgujDjEnTJu2LMCz-GVhYcNXXkKa3bYY2GZN0dF_95Gac7jKVfZA-pDS_c9J7bm6SPCd4RSgn77Z2dEb2q501sMIpLmmJHyTnpKTpkqWYPjx5P0ueeL_FOKcFY4-TM4pZjnFRnCe_1_V2NCqgXSdbQMGBDAOYgMB00ijwKHSAoGlABb0HA94j26De_kTSBF1pG7RCykbUBCeDtgbJVmrjA7oOctfd9FZZpUaP5OggLlHS6H7wSBu018HZp8mjRvYenk3rIvn28cPXi8_Ly6tPm4v15VKxMg3LJs1whjFLSZpxCqrmpSR5zQtakLKqeZ2WLE15AzjGU-IccJPhikGloMqhqegieXn03fXWiyk-L1LCOC84jkaLZHMkaiu3Yuf0IN2NsFKLvx-sa4V0sd4eBMOkzChNszyHjJO6qlVVE0VpDZnKMxm93k-njdUA9TGefmY63zG6E63dC0ZpFnsZDd5MBs7-GMEHMWivoO-lATse_puXMQ_OSURf_YPeX91EtTIWoE1j47nqYCrWOSuLDLOSRmp1DxWfGgYd-wyxeTAXvJ0JIhPgV2jl6L3YXH_5f_bq-5x9fcJ2IPvQeduPhyvm52B2BJWz3jto7kImWBxG5TYNcRgVMY1KlL04bdCd6HY26B_Y2hDl</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2167787078</pqid></control><display><type>article</type><title>Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Dickey, James ; Perrot, Véronique</creator><creatorcontrib>Dickey, James ; Perrot, Véronique</creatorcontrib><description>Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infections as they are inherently refractory to many types of antibiotics. Treating biofilms with phage has shown promise in a handful of experimental and case studies. However, quantification of the effect of phage combined with antibiotics is needed to pave the way for larger clinical trials. Here we explore the effect of using phage in combination with a total of nine antibiotics, applied simultaneously or as a pretreatment before antibiotics are applied to in vitro biofilms of Staphylococcus aureus. Most antibiotics alone were ineffective at low concentration (2×MIC), but the addition of phage to treatment regimens led to substantial improvements in efficacy. At high concentration (10×MIC), antibiotics alone were effective, and in most cases the addition of phage to treatment regimens did not improve efficacy. Using phage with rifampin was also very effective at reducing the outgrowth of resistant strains during the course of treatment.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0209390</identifier><identifier>PMID: 30650088</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Anti-Bacterial Agents - administration & dosage ; Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; Bacteria ; Bacterial infections ; Bacteriophages - ultrastructure ; Biofilms ; Biofilms - drug effects ; Biofilms - growth & development ; Biology and Life Sciences ; Care and treatment ; Clinical trials ; Combined Modality Therapy ; Drug resistance ; Drug Resistance, Bacterial ; Health risks ; Humans ; In Vitro Techniques ; Infectious diseases ; Integrated approach ; Medical research ; Medicine and Health Sciences ; Microbial drug resistance ; Microbial Sensitivity Tests ; Microscopy ; Microscopy, Electron, Transmission ; Minimum inhibitory concentration ; Pathogens ; Phage Therapy ; Phages ; Public health ; Rifampin ; Skin ; Staphylococcal Infections - therapy ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - physiology ; Staphylococcus aureus infections ; Staphylococcus infections</subject><ispartof>PloS one, 2019-01, Vol.14 (1), p.e0209390-e0209390</ispartof><rights>COPYRIGHT 2019 Public Library of Science</rights><rights>2019 Dickey, Perrot. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 Dickey, Perrot 2019 Dickey, Perrot</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-f2404006212473ecd79a15d783819bd7d296227fe0137905e0f40b6ebceb5efb3</citedby><cites>FETCH-LOGICAL-c692t-f2404006212473ecd79a15d783819bd7d296227fe0137905e0f40b6ebceb5efb3</cites><orcidid>0000-0001-9517-5118</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334939/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334939/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30650088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dickey, James</creatorcontrib><creatorcontrib>Perrot, Véronique</creatorcontrib><title>Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infections as they are inherently refractory to many types of antibiotics. Treating biofilms with phage has shown promise in a handful of experimental and case studies. However, quantification of the effect of phage combined with antibiotics is needed to pave the way for larger clinical trials. Here we explore the effect of using phage in combination with a total of nine antibiotics, applied simultaneously or as a pretreatment before antibiotics are applied to in vitro biofilms of Staphylococcus aureus. Most antibiotics alone were ineffective at low concentration (2×MIC), but the addition of phage to treatment regimens led to substantial improvements in efficacy. At high concentration (10×MIC), antibiotics alone were effective, and in most cases the addition of phage to treatment regimens did not improve efficacy. Using phage with rifampin was also very effective at reducing the outgrowth of resistant strains during the course of treatment.</description><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Bacteriophages - ultrastructure</subject><subject>Biofilms</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth & development</subject><subject>Biology and Life Sciences</subject><subject>Care and treatment</subject><subject>Clinical trials</subject><subject>Combined Modality Therapy</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Health risks</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Infectious diseases</subject><subject>Integrated approach</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Microbial drug resistance</subject><subject>Microbial Sensitivity Tests</subject><subject>Microscopy</subject><subject>Microscopy, Electron, Transmission</subject><subject>Minimum inhibitory concentration</subject><subject>Pathogens</subject><subject>Phage Therapy</subject><subject>Phages</subject><subject>Public health</subject><subject>Rifampin</subject><subject>Skin</subject><subject>Staphylococcal Infections - therapy</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - physiology</subject><subject>Staphylococcus aureus infections</subject><subject>Staphylococcus infections</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1-L1DAUxYso7jr6DUQDgujDjEnTJu2LMCz-GVhYcNXXkKa3bYY2GZN0dF_95Gac7jKVfZA-pDS_c9J7bm6SPCd4RSgn77Z2dEb2q501sMIpLmmJHyTnpKTpkqWYPjx5P0ueeL_FOKcFY4-TM4pZjnFRnCe_1_V2NCqgXSdbQMGBDAOYgMB00ijwKHSAoGlABb0HA94j26De_kTSBF1pG7RCykbUBCeDtgbJVmrjA7oOctfd9FZZpUaP5OggLlHS6H7wSBu018HZp8mjRvYenk3rIvn28cPXi8_Ly6tPm4v15VKxMg3LJs1whjFLSZpxCqrmpSR5zQtakLKqeZ2WLE15AzjGU-IccJPhikGloMqhqegieXn03fXWiyk-L1LCOC84jkaLZHMkaiu3Yuf0IN2NsFKLvx-sa4V0sd4eBMOkzChNszyHjJO6qlVVE0VpDZnKMxm93k-njdUA9TGefmY63zG6E63dC0ZpFnsZDd5MBs7-GMEHMWivoO-lATse_puXMQ_OSURf_YPeX91EtTIWoE1j47nqYCrWOSuLDLOSRmp1DxWfGgYd-wyxeTAXvJ0JIhPgV2jl6L3YXH_5f_bq-5x9fcJ2IPvQeduPhyvm52B2BJWz3jto7kImWBxG5TYNcRgVMY1KlL04bdCd6HY26B_Y2hDl</recordid><startdate>20190116</startdate><enddate>20190116</enddate><creator>Dickey, James</creator><creator>Perrot, Véronique</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9517-5118</orcidid></search><sort><creationdate>20190116</creationdate><title>Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro</title><author>Dickey, James ; Perrot, Véronique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-f2404006212473ecd79a15d783819bd7d296227fe0137905e0f40b6ebceb5efb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Bacteriophages - ultrastructure</topic><topic>Biofilms</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth & development</topic><topic>Biology and Life Sciences</topic><topic>Care and treatment</topic><topic>Clinical trials</topic><topic>Combined Modality Therapy</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Health risks</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Infectious diseases</topic><topic>Integrated approach</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Microbial drug resistance</topic><topic>Microbial Sensitivity Tests</topic><topic>Microscopy</topic><topic>Microscopy, Electron, Transmission</topic><topic>Minimum inhibitory concentration</topic><topic>Pathogens</topic><topic>Phage Therapy</topic><topic>Phages</topic><topic>Public health</topic><topic>Rifampin</topic><topic>Skin</topic><topic>Staphylococcal Infections - therapy</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - physiology</topic><topic>Staphylococcus aureus infections</topic><topic>Staphylococcus infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dickey, James</creatorcontrib><creatorcontrib>Perrot, Véronique</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dickey, James</au><au>Perrot, Véronique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2019-01-16</date><risdate>2019</risdate><volume>14</volume><issue>1</issue><spage>e0209390</spage><epage>e0209390</epage><pages>e0209390-e0209390</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infections as they are inherently refractory to many types of antibiotics. Treating biofilms with phage has shown promise in a handful of experimental and case studies. However, quantification of the effect of phage combined with antibiotics is needed to pave the way for larger clinical trials. Here we explore the effect of using phage in combination with a total of nine antibiotics, applied simultaneously or as a pretreatment before antibiotics are applied to in vitro biofilms of Staphylococcus aureus. Most antibiotics alone were ineffective at low concentration (2×MIC), but the addition of phage to treatment regimens led to substantial improvements in efficacy. At high concentration (10×MIC), antibiotics alone were effective, and in most cases the addition of phage to treatment regimens did not improve efficacy. Using phage with rifampin was also very effective at reducing the outgrowth of resistant strains during the course of treatment.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>30650088</pmid><doi>10.1371/journal.pone.0209390</doi><tpages>e0209390</tpages><orcidid>https://orcid.org/0000-0001-9517-5118</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2019-01, Vol.14 (1), p.e0209390-e0209390 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2167787078 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Anti-Bacterial Agents - administration & dosage Antibiotic resistance Antibiotics Antimicrobial agents Bacteria Bacterial infections Bacteriophages - ultrastructure Biofilms Biofilms - drug effects Biofilms - growth & development Biology and Life Sciences Care and treatment Clinical trials Combined Modality Therapy Drug resistance Drug Resistance, Bacterial Health risks Humans In Vitro Techniques Infectious diseases Integrated approach Medical research Medicine and Health Sciences Microbial drug resistance Microbial Sensitivity Tests Microscopy Microscopy, Electron, Transmission Minimum inhibitory concentration Pathogens Phage Therapy Phages Public health Rifampin Skin Staphylococcal Infections - therapy Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - physiology Staphylococcus aureus infections Staphylococcus infections |
title | Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T14%3A20%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adjunct%20phage%20treatment%20enhances%20the%20effectiveness%20of%20low%20antibiotic%20concentration%20against%20Staphylococcus%20aureus%20biofilms%20in%20vitro&rft.jtitle=PloS%20one&rft.au=Dickey,%20James&rft.date=2019-01-16&rft.volume=14&rft.issue=1&rft.spage=e0209390&rft.epage=e0209390&rft.pages=e0209390-e0209390&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0209390&rft_dat=%3Cgale_plos_%3EA569840693%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2167787078&rft_id=info:pmid/30650088&rft_galeid=A569840693&rft_doaj_id=oai_doaj_org_article_60194332455e471dbdcbd1c33de4c54a&rfr_iscdi=true |